Augmentation of CO2 drives by chlormadinone acetate, a synthetic progesterone.
We studied 10 male subjects who were administered chlormadinone acetate (CMA), a potent synthetic progesterone, to clarify the physiological basis of its respiratory effects. Arterial blood gas tension, resting ventilation, and respiratory drive assessed by ventilatory and occlusion pressure response to CO2 with and without inspiratory flow-resistive loading were measured before and 4 wk after CMA administration. In all subjects, arterial PCO2 decreased significantly by 5.7 +/- 0.6 (SE) Torr with an increase in minute ventilation by 1.8 +/- 0.6 l X min-1, whereas no significant changes were seen in O2 uptake. During unloaded conditions, both slopes of occlusion pressure and ventilatory response to CO2 increased, being statistically significant in the former but showing nonsignificant trends in the latter. Furthermore, inspiratory flow-resistive loading (16 cmH2O X l(-1) X s) increased both slopes more markedly after CMA. The magnitudes of load compensation, assessed by the ratio of loaded to unloaded slope of the occlusion pressure response curve, were increased significantly. We concluded CMA is a potent respiratory stimulant that increases the CO2 chemosensitivity and neuromechanical drives in the load-compensation mechanism.
D000368:Aged; D002245:Carbon Dioxide / Q000494:pharmacology / Q000502:physiology*; D002715:Chlormadinone Acetate / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011312:Pressure; D011374:Progesterone / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D014939:Work of Breathing
D002715:Chlormadinone Acetate; D002245:Carbon Dioxide; D011374:Progesterone